Acetaminophen: clinical trials recruiting now
5
Recruiting trials
6
Conditions studied
4
US states with sites
3
Countries
FDA drug label
- FDA-approved
- Yes. Acetaminophen appears in the FDA drug-label database. Marketed as Pain Reliever Extra Strength.
FDA-approved use
Uses temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier. — Perrigo Company PLC | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2021-10-26 |
| Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle. — Contract Pharmacal Corporation | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2020-02-03 |
| Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label. — A-S Medication Solutions LLC. | Class I (FDA: reasonable probability of serious harm or death) | Terminated | 2021-03-02 |
| Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenes — Reckitt Benckiser LLC | Class I (FDA: reasonable probability of serious harm or death) | Terminated | 2015-04-15 |
| Defective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings. — L. Perrigo Co. | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2013-11-01 |
Phase breakdown
Phase 1 4
Phase 2 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Obesity · Acetaminophen for Obesity | 3 |
| Overweight · Acetaminophen for Overweight | 3 |
| Crohn's disease | 2 |
| Crohn Disease | 1 |
| Crohn's Disease (CD) | 1 |
| Dysmenorrhea Primary | 1 |
Recruiting trials involving Acetaminophen
- A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
- Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)
- Stem Cell Transplantation in Crohn's Disease
Common questions
Is Acetaminophen FDA-approved?
Yes, marketed as Pain Reliever Extra Strength.
How many recruiting trials involve Acetaminophen?
5 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.